PDK2: A Protein with Unique Structure and Potential as A Drug Target Or Biomarker

Target Name: PDK2

NCBI ID: G5164

PDK2

PDK2: A Protein with Unique Structure and Potential as A Drug Target Or Biomarker

PDK2 (Pay-And-Click) is a protein that is expressed in nearly all tissues of the body. It is a key regulator of cell-cell adhesion and has been implicated in a number of diseases, including cancer. In recent years, researchers have been interested in using PDK2 as a drug target or biomarker because of its unique structure and the potential it holds for the development of new treatments.

PDK2 is a transmembrane protein that is expressed in the cells that make up the nervous system, including neurons and glial cells. It is composed of four domains: an extracellular domain, a transmembrane domain, an intracellular domain, and a catalytic domain. The extracellular domain is responsible for the protein's ability to interact with cell-cell adhesion, while the transmembrane domain helps to maintain the protein's structural integrity. The intracellular domain is responsible for the protein's ability to interact with and regulate the activity of other proteins, and the catalytic domain is responsible for the protein's catalytic activity.

PDK2 has been shown to play a role in a number of important biological processes, including cell-cell adhesion, migration, and the regulation of ion channels. It has also been implicated in a number of diseases, including cancer. For example, studies have shown that PDK2 is often overexpressed in cancer cells and that inhibiting its activity may be an effective way to treat cancer. Additionally, PDK2 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

PDK2 has also been shown to be a potential biomarker for a number of diseases. For example, studies have shown that PDK2 is often overexpressed in the brains of individuals with Alzheimer's disease, and that inhibiting its activity may be an effective way to treat the disease. Additionally, PDK2 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and may be a useful biomarker for these conditions.

In addition to its potential as a drug target or biomarker, PDK2 is also of interest to researchers because of its unique structure and the potential it holds for the development of new treatments. For example, researchers are interested in using PDK2 as a target for small molecules because of its transmembrane structure and the potential it holds for the development of targeted therapies. Additionally, researchers are also interested in using PDK2 as a target for antibodies because of its extracellular domain and the potential it holds for the development of new immunotherapies.

In conclusion, PDK2 is a protein that has been shown to play a number of important roles in a variety of biological processes. As a result, it has been the focus of a great deal of research in recent years, and its unique structure and the potential it holds for the development of new treatments make it an intriguing candidate as a drug target or biomarker. Further research is needed to fully understand the role of PDK2 in biology and to develop new treatments based on its unique properties.

Protein Name: Pyruvate Dehydrogenase Kinase 2

Functions: Kinase that plays a key role in the regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate dehydrogenase activity, and thereby regulates metabolite flux through the tricarboxylic acid cycle, down-regulates aerobic respiration and inhibits the formation of acetyl-coenzyme A from pyruvate. Inhibition of pyruvate dehydrogenase decreases glucose utilization and increases fat metabolism. Mediates cellular responses to insulin. Plays an important role in maintaining normal blood glucose levels and in metabolic adaptation to nutrient availability. Via its regulation of pyruvate dehydrogenase activity, plays an important role in maintaining normal blood pH and in preventing the accumulation of ketone bodies under starvation. Plays a role in the regulation of cell proliferation and in resistance to apoptosis under oxidative stress. Plays a role in p53/TP53-mediated apoptosis

The "PDK2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDK2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets